Skip to main content
    I

    Intuitive Surgical Inc (ISRG)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $437.75
    -5.84 (-1.32%)

    Market Cap: $153.77B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Intuitive Surgical Inc (ISRG) Financials: Revenue, Profit and Cash Flow

    Updated Oct 20, 2026. Financial statements from company filings, amounts in US dollars.

    Intuitive Surgical reported revenue of $10.06B for the fiscal year ended Dec 31, 2025, up 20.5% from the year before. That year, net income was $2.88B with a net margin of 28.6%, operating cash flow was $3.03B and free cash flow was $2.49B. The quarter ended Sep 30, 2026 had revenue of $3.05B and net income of $524.40M.

    Revenue and Margins

    The operating margin was 29.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.71B, a compound annual rate of 15.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$10.06B+20.5%66.0%29.3%28.6%
    Dec 2024$8.35B+17.2%67.5%28.1%28.0%
    Dec 2023$7.12B+14.5%66.4%24.8%25.5%
    Dec 2022$6.22B+9.0%67.4%25.3%21.6%
    Dec 2021$5.71B+31.0%69.3%31.9%30.3%
    Dec 2020$4.36B-2.7%65.6%24.1%24.5%
    Dec 2019$4.48B+20.3%69.4%30.7%30.9%
    Dec 2018$3.72B+18.7%69.9%32.2%30.2%
    Dec 2017$3.14B+16.0%70.2%33.9%21.4%
    Dec 2016$2.71BN/A69.9%35.1%27.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 23.1% from the year before. In the quarter ended Sep 2026, net income fell 26.1% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$10.06B$8.35B$7.12B$6.22B$5.71B$4.36B$4.48B$3.72B$3.14B$2.71B
    Cost of revenue$3.42B$2.72B$2.39B$2.03B$1.75B$1.50B$1.37B$1.12B$936.20M$813.60M
    Gross profit$6.64B$5.63B$4.73B$4.20B$3.96B$2.86B$3.11B$2.60B$2.20B$1.89B
    Research and development$1.31B$1.15B$998.80M$879.00M$671.00M$595.10M$557.30M$418.10M$328.60M$239.60M
    Operating income$2.95B$2.35B$1.77B$1.58B$1.82B$1.05B$1.37B$1.20B$1.06B$949.70M
    Net income$2.88B$2.34B$1.82B$1.34B$1.73B$1.07B$1.38B$1.13B$670.90M$738.30M
    EBITDA$3.93B$3.13B$2.42B$2.05B$2.23B$1.45B$1.71B$1.41B$1.24B$1.12B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.05B$2.89B$2.77B$2.87B$2.51B$2.44B$2.25B$2.41B$2.04B$2.01B$1.89B$1.93B
    Gross profit$2.08B$1.96B$1.83B$1.90B$1.66B$1.62B$1.46B$1.64B$1.37B$1.37B$1.25B$1.28B
    Operating income$592.60M$971.90M$855.30M$864.30M$759.70M$743.40M$578.10M$734.90M$577.30M$567.30M$469.40M$450.20M
    Net income$524.40M$823.20M$826.00M$799.50M$709.20M$664.20M$703.70M$688.00M$570.60M$531.50M$547.40M$610.70M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $549.80M by $2.82B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$20.46B$18.74B$15.44B$12.97B$13.55B$11.17B$9.73B$7.85B$5.78B$6.49B
    Current assets$9.78B$7.11B$7.89B$6.25B$5.84B$6.63B$4.66B$4.33B$2.81B$3.25B
    Cash and equivalents$3.37B$2.03B$2.75B$1.58B$1.29B$1.62B$1.17B$857.90M$648.20M$1.04B
    Total liabilities$2.52B$2.21B$2.04B$1.86B$1.60B$1.41B$1.45B$1.16B$996.40M$709.10M
    Short-term debt$39.00M$33.50M$25.30M$24.20M$20.40M$21.90M$568.90M$39.10M$371.90M$143.70M
    Long-term debt$510.80M$468.30M$385.50M$439.30M$453.70M$444.60M$418.30M$338.60M$333.60M$0
    Shareholder equity$17.82B$16.43B$13.31B$11.04B$11.90B$9.73B$8.26B$6.68B$4.78B$5.78B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$19.35B$20.88B$20.11B$20.63B$19.35B$20.16B$19.22B$18.84B$17.74B$16.65B$15.83B$15.44B
    Total liabilities$3.23B$2.58B$2.51B$2.69B$2.31B$2.21B$2.01B$2.31B$2.07B$1.85B$1.78B$2.04B
    Cash and equivalents$2.98B$2.76B$2.01B$3.37B$2.81B$3.40B$2.57B$2.03B$2.41B$3.04B$2.84B$2.75B
    Shareholder equity$15.99B$18.17B$17.47B$17.82B$16.93B$17.85B$17.11B$16.43B$15.58B$14.71B$13.96B$13.31B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 82.2% of operating cash flow. Share repurchases came to 92.4% of it, with no dividends.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$3.03B$2.42B$1.81B$1.49B$2.09B$1.48B$1.60B$1.17B$1.14B$1.09B
    Capital expenditures$539.80M$1.11B$1.06B$532.40M$339.50M$341.50M$425.60M$187.40M$190.70M$53.90M
    Free cash flow$2.49B$1.30B$749.60M$958.40M$1.75B$1.14B$1.17B$982.20M$953.20M$1.03B
    Dividends paid$0$8.00M$0$0N/AN/AN/AN/A$0$0
    Share repurchases$2.30B$0$416.30M$2.61B$0$134.30M$269.50M$0$2.27B$42.50M
    Investing cash flow$665.80M-$3.27B-$360.10M$1.37B-$2.46B-$940.60M-$1.15B-$1.05B$378.70M-$1.28B
    Financing cash flow-$2.36B$150.90M-$287.60M-$2.57B$43.00M-$85.70M-$168.40M$126.30M-$1.91B$514.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$1.22B$1.06B$911.90M$892.50M$841.00M$715.40M$581.60M$822.60M$706.50M$620.50M$265.40M$228.30M
    Capital expenditures$113.10M$112.60M$103.30M$162.50M$105.40M$155.30M$116.60M$312.00M$247.90M$309.40M$241.90M$435.50M
    Free cash flow$1.11B$948.40M$808.60M$730.00M$735.60M$560.10M$465.00M$510.60M$458.60M$311.10M$23.50M-$207.20M
    Last 12 quarters

    Frequently Asked Questions About ISRG

    What is Intuitive Surgical's annual revenue?

    Intuitive Surgical reported revenue of $10.06B for the fiscal year ended Dec 31, 2025.

    How fast is Intuitive Surgical's revenue growing?

    Revenue was up 20.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 17.4%.

    Is Intuitive Surgical profitable?

    Yes. Intuitive Surgical reported net income of $2.88B for the fiscal year ended Dec 31, 2025, with a net margin of 28.6%.

    How much free cash flow does ISRG generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $3.03B minus capital expenditures of $539.80M produced free cash flow of $2.49B.

    How much debt does Intuitive Surgical have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $510.80M, short-term debt of $39.00M and cash and equivalents of $3.37B.